Eon Labs Begins Shipping Nabumetone Tablets

Business Wire, Feb 26, 2002

Business Editors

NEW YORK--(BUSINESS WIRE)--February 26, 2002

Eon Labs, Inc. began shipping Nabumetone 500mg and 750mg tablets, the FDA approved generic equivalent of the brand Relafen(R)(a).

Relafen/generic Nabumetone experienced sales of nearly $300 million in the past 12 months (b). Eon Labs Nabumetone is available in the same strengths as the brand, 500mg and 750mg tablets. Eon is packaging both strengths in 100 count bottles, like the brand, as well as 500 count bottles.

Eon Labs, Inc. is one of the leading generic pharmaceutical companies in the U.S. For further information on products manufactured and distributed by Eon Labs, please call 1-800-526-0225, write to Eon Labs, Inc., 227-15 N. Conduit Avenue, Laurelton, N.Y. 11413, or visit www.eonlabs.com.

(a) Relafen is a registered trademark of GlaxoSmithKline and is

not affiliated with Eon Labs, Inc.

(b) Source: Scott-Levin; 12 months to January 2002.